Google is currently leaving no stone unturned by exploring the medical, defense, technological, and other fields as well. Google has currently developed an artificial intelligence (AI) system in order to help save the time of the doctors for the last stage cancer patient’s breast cancer treatments.
According to the tech giant, the novel AI can help spot out secondary cancer cells that too with 99pc accuracy. These cells are normally cumbersome to detect when under time constraints. Thus, the pathologists can now rejoice as their conventional 81pc accuracy device has now got a supreme competitor. The basic reason for coming up with such a technology is to detect the secondary cancer cells that generally break away from the primary cancer mass and develop in other body parts. For avoiding the spread of cancer and also saving time for the patient, Google has developed novel software.
Google has named its AI “Lymph Node Assistant (LYNA)” which has been designed such that it can characterize and recognize the tumors in the patients from the previous scans. The AI helped doctors carry out the cancer scan inspection within halftime and also with better precision. The healthcare is currently using a lot of AI for a number of functions including a 3D scan of the eyes, smart person recognition, and so on. The present technology is surely going to help save millions of women by extending their lifespan. The in-depth study in the field of cancer along with the implementation of technology is a profitable combination the humanity has been waiting for.
Scott Newman and his team from the St. Jude Children’s Research Hospital have found that the complete genetic testing including RNA sequencing and whole genome or exome sequencing of tumors and non-cancerous tissues in the pediatric cancer patients is a reasonable and clinically handy approach in terms of patient care. Thus, the sequencing data seems to be fool-proof in the long run for tackling the disease.